Vimarsana
Biggest News Aggregation in the World

Page 30 - Stock Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stock Code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stock Code Today - Breaking & Trending Today

SF Intra-city Plans to Repurchase Shares at a Maximum of HK$200 million - Vimarsana News

SF Intra-city Plans to Repurchase Shares at a Maximum of HK$200 million

/PRNewswire/ -- Hangzhou SF Intra-city Industrial Co., Ltd. (Stock Code: 9699.HK), China's largest third-party on-demand delivery service provider, is pleased...

Malaysia's Homegrown AGAPE ATP Corporation Makes Landmark Transition to NASDAQ, Excelling on International Stage - Vimarsana News

Malaysia's Homegrown AGAPE ATP Corporation Makes Landmark Transition to NASDAQ, Excelling on International Stage

- AGAPE ATP Corporation , a leading player in Malaysia's sustainable health and wellness sector, announced its successful transition from the Over the Counter to Nasdaq stock exchange today at a...

AGAPE ATP Corporation Makes Landmark Transition to NASDAQ - Vimarsana News

AGAPE ATP Corporation Makes Landmark Transition to NASDAQ

AGAPE ATP Corporation Makes Landmark Transition to NASDAQ

Asieris Unveiled Results of Its Phase III Clinical Study for APL-1706, an Imaging Drug for Diagnosis or Surgery of Bladder Cancer, at the SIU 2023 Congress - Vimarsana News

Asieris Unveiled Results of Its Phase III Clinical Study for APL-1706, an Imaging Drug for Diagnosis or Surgery of Bladder Cancer, at the SIU 2023 Congress

/PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing...

CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survival - Vimarsana News

CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survival

/PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of...